Accelerating clinical development in Vienna

Gouya Insights, VelaLabs – a Tentamus company -, and ABF Pharmaceutical Services offer a one-stop solution to accelerate development and de-risk clinical translation. In the competitive world of biotechnology, companies face complex challenges in translating discoveries into successful clinical programs. With the right guidance, biotech companies can avoid unnecessary delays in preclinical development and move confidently toward clinical success.

ClinXTrials unites deep expertise in clinical development, bioanalytic, and trial logistics to provide an integrated, end-to-end solution. Under the umbrella of ClinXTrials a broad portfolio of services can be provided and enhance the success of clinical development programs.

Emerging biotech companies often require expert guidance to navigate the complex regulatory and financial landscape: from identifying unmet medical need and defining a Target Product Profile (TPP), to developing a clear milestone plan, robust financial models and sound clinical strategy.

Gouya Insights (https://gouya-insights.com/) brings together seasoned experts in clinical strategy, non-clinical development, toxicology, and manufacturing to pave a clear path towards clinical stage- while also delivering full operational support to ensure successful clinical trial execution.

VelaLabs serves as your compass through complex clinical trial sample analytics. VelaLabs (https://www.vela-labs.at/) is offering pharmacokinetic (PK), pharmacodynamic (PD) and immunogenicity (ADA, anti-drug antibody) services on several analytical platforms tailored to the client´s needs. This ensures comprehensive support for clients from the pre-clinical stage through all phases of clinical development are guaranteed thanks to a broad portfolio of analytical assays ranging from immunoassays to cell-based assays and surface marker analysis.

Clinical trial supply and trial logistics demand specialized expertise, a strength provided by ABF Pharmaceutical Services (https://www.gba-group.com/…), a member of the GBA Group. Their extensive services span the entire supply chain, from label design and GMP-compliant printing to customized primary and secondary packaging. ABF also manages sample collection, reconciliation, GMP storage and GDP-compliant transport, comparator sourcing (including biosimilars and combination therapies), import/export handling, customs clearance, and QP release-ensuring seamless and compliant trial execution.

While individually contributing to a clinical development program for a shared client, the value of close collaboration quickly became clear – sparking the idea to form a unique alliance dedicated to accelerating such programs. ClinXTrials doesn’t just support clinical development – it accelerates it, guiding emerging biotech companies to reach their milestones faster, with confidence, efficiency and excellence.  Based in the heart of Europe, we are proud to contribute to Vienna’s growing reputation as a premier hub for clinical development.

Follow us on social media:

https://www.linkedin.com/company/tentamus-group/

https://www.instagram.com/tentamus/